UBS’s Neogen NEOG Stock Holding History

UBS’s Portfolio NEOG Stock Details NEOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$59K	Buy	+4,000	New	+$63.1K	﹤0.01%	6634

Other funds holding NEOG

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS's NEOG Position: Q3 2014 in Review

UBS reduced its Neogen (NEOG) stake by 0.31% in Q3 2014, selling an estimated $14K and leaving 281,800 shares worth $4.17M. The position accounts for ﹤0.01% of the portfolio, ranked #2205.

UBS first reported a position in NEOG in Q2 2013 and has held it in 6 quarters since. The position peaked at $5.58M in Q4 2013. 188 funds tracked by Wall St. Rank hold NEOG as of Q3 2014.

UBS held 281,800 shares of Neogen worth $4.17M as of Q3 2014.
UBS sold 888 Neogen shares in Q3 2014, an estimated $14K.
Neogen made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2205 holding.
UBS first reported a position in Neogen in Q2 2013 and has held it in 6 quarters since.
UBS's Neogen position peaked at $5.58M in Q4 2013.
188 funds tracked by Wall St. Rank held Neogen as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.